Recommended Pages at prescriptions.blogs.nytimes.com
A Note to Readers of This Blog - NYTimes.com
prescriptions.blogs.nytimes.com — “The Times is discontinuing the Prescriptions blog.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on February 24, 2012 at 6:43 pm By:
A Note to Readers of This Blog http://t.co/OMvIvlgl
F.D.A. Approves Drug for an Advanced Skin Cancer - NYTimes.com
prescriptions.blogs.nytimes.com — “The drug, Erivedge, made by Genentech, was approved for adults with basal cell carcinoma that has spread elsewhere in the body or those who are not candidates for surgery or radiation.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 30, 2012 at 8:48 pm By:
F.D.A. Approves Drug for an Advanced Skin Cancer http://t.co/JMn8oA89
Despite Generic Rivals, Branded Drugs Still Sell Well - NYTimes.com
prescriptions.blogs.nytimes.com — “Drug companies are finding lucrative foreign markets for their brand-name drugs after patents expire in the United States and unleash generic competition.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 25, 2012 at 10:45 pm By:
Despite Generic Rivals, Branded Drugs Still Sell Well - http://t.co/9R214o6V #pharma
Despite Generic Rivals, Branded Drugs Still Sell Well - NYTimes.com
prescriptions.blogs.nytimes.com — “Drug companies are finding lucrative foreign markets for their brand-name drugs after patents expire in the United States and unleash generic competition.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 25, 2012 at 9:45 pm By:
Despite Generic Rivals, Branded Drugs Still Sell Well http://t.co/Inv2Apsn
Doctors Refer More Patients to Specialists - NYTimes.com
prescriptions.blogs.nytimes.com — “A new study finds that primary care doctors are referring patients to other doctors at double the rate of a decade ago. The reasons are unclear but the researchers say the practice is driving up health care costs.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 23, 2012 at 9:37 pm By:
Wayne Guerra Emergency Physician, Physician, and Doctor
Study: Physicians refer patients to specialists twice as often now than in 1999. http://t.co/E4c9V8I8 #physicians
F.D.A. Delays Approval of New Diabetes Drug - NYTimes.com
prescriptions.blogs.nytimes.com — “Federal drug regulators are seeking more data from AstraZeneca and Bristol-Myers Squibb before deciding whether to approve dapagliflozin, a new drug aimed at Type 2 diabetes.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 20, 2012 at 4:50 pm By:
Scott Strumello Patient Expert
http://t.co/FLXrivWW: FDA Delays Approval of New Type 2 Diabetes Drug http://t.co/R4oNaETg
F.D.A. Delays Approval of New Diabetes Drug - NYTimes.com
prescriptions.blogs.nytimes.com — “Federal drug regulators are seeking more data from AstraZeneca and Bristol-Myers Squibb before deciding whether to approve dapagliflozin, a new drug aimed at Type 2 diabetes.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 19, 2012 at 7:20 pm By:
F.D.A. Delays Approval of New Diabetes Drug http://t.co/C3QXhNT9
New Questions Raised About Tamiflu's Effectiveness - NYTimes.com
prescriptions.blogs.nytimes.com — “A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 18, 2012 at 12:31 am By:
Prescriptions Blog: New Questions Raised About Tamiflu's Effectiveness: A new study by the Cochrane Collaboratio... http://t.co/USIZmcHW
New Questions Raised About Tamiflu's Effectiveness - NYTimes.com
prescriptions.blogs.nytimes.com — “A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 18, 2012 at 12:06 am By:
New Questions Raised About Tamiflu's Effectiveness http://t.co/uU93MpsJ
More Health Clinics Pop Up Inside Retailers - NYTimes.com
prescriptions.blogs.nytimes.com — “The number of medical clinics inside retail stores is expected to boom, in part because of incentives under the new federal health care law. Chains like Safeway and Walmart already have big expansion plans.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 9, 2012 at 11:35 pm By:
Leigh Ann Otte Health Magazine
Ever visited a clinic inside a store (Safeway, Walmart)? RT @nytimeshealth More Health Clinics Pop Up Inside Retailers http://t.co/ZgxzudW0
More Health Clinics Pop Up Inside Retailers - NYTimes.com
prescriptions.blogs.nytimes.com — “The number of medical clinics inside retail stores is expected to boom, in part because of incentives under the new federal health care law. Chains like Safeway and Walmart already have big expansion plans.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on January 9, 2012 at 11:01 pm By:
More Health Clinics Pop Up Inside Retailers http://t.co/cZgzabZx
Walgreen Girds for Fight Over Pharmacy Customers - NYTimes.com
prescriptions.blogs.nytimes.com — “Walgreen to introduce a national plan it hopes will minimize customer disruption from its contract battle with its pharmacy benefits manager, Express Scripts.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on December 30, 2011 at 6:24 pm By:
Walgreen Girds for Fight Over Customers http://t.co/NEvPijog
Final Rules Set for Insurers on Spending Ratios - NYTimes.com
prescriptions.blogs.nytimes.com — “The industry did not get an exemption for brokers' fees under the regulations for how much of a customer's premium must be spent on medical care.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on December 12, 2011 at 6:34 pm By:
Final Rules Set for Insurers on Spending Ratios http://t.co/qD4gGj4t
New Setback for Avastin as Breast Cancer Treatment - NYTimes.com
prescriptions.blogs.nytimes.com — “The latest trial, had it been more successful, could have paved the way for a new approval.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on December 8, 2011 at 3:44 pm By:
New Setback for Avastin as Breast Cancer Treatment http://t.co/Vjq3Cvwe
New Breast Cancer Test May Help Curtail Treatments - NYTimes.com
prescriptions.blogs.nytimes.com — “Genomic Health is planning to release results of the test's accuracy on Thursday at a breast cancer symposium.” View full resource at prescriptions.blogs.nytimes.com
Most Recently Shared on December 6, 2011 at 11:33 pm By:
New Breast Cancer Test May Help Curtail Treatments http://t.co/8Z5b8MiM
